ArticleFrontiers in neurology2025
Correlation between fatigue and quality of life among patients with neuromyelitis optica in West China.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the current status and determinants of fatigue and to examine the relationship between fatigue and quality of life (QOL) in patients with neuromyelitis optica (NMO). Methods: Eligible patients with NMO were assessed with the Fatigue Impact Scale (FIS) and the Chinese version of the Multiple Sclerosis Quality of Life-54 (MSQOL-54). Clinical factors influencing fatigue were explored and the association between fatigue and QOL was analyzed. Results: Sixty-nine patients (mean age 40.13 years, male/female 6/63) were enrolled. The median Expanded Disability Status Scale (EDSS) score was 3, and 75.4% were seropositive for NMO-IgG. The total FIS score was 67.12 ± 41.24, accounted for by the three sub-dimensions: cognitive fatigue 13.80 ± 9.63, physical fatigue 20.48 ± 12.93, and psychosocial fatigue 32.84 ± 20.94. EDSS scores were positively correlated with total fatigue and all its subdomains; the number of relapses was positively correlated with cognitive fatigue; total fatigue and its subdomains were moderately and negatively correlated with all QOL dimensions. Conclusion: Disability status in NMO patients is associated with overall fatigue and its subdomains; relapse frequency is linked to cognitive fatigue; fatigue is negatively correlated with quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.